Cambridge Innovation Capital plc (“CIC” or “the Company”), a preferred investor for the University of Cambridge and a Cambridge-based investor in technology and healthcare companies, announces that it has raised £75 million of new capital (the “Fundraising”).
CIC was founded in 2013 as an initiative by the University of Cambridge to create a local entity that would be able to provide growth capital to promising businesses arising from the University of Cambridge and the wider Cambridge Cluster, Europe’s largest technology cluster. CIC provides long term capital to support the sustained growth of investee companies.
CIC is a preferred investor of the University of Cambridge and has a unique relationship with Cambridge Enterprise, the commercialisation arm of the University, including co-investment opportunities and access to pre-emption rights over companies arising out of the University. In addition, CIC has established an unrivalled position within the Cambridge Cluster. To date, the Company has committed approximately £33 million to 13 companies in the rapidly-growing technology and healthcare sectors.
The new funds raised will be used to provide additional investment to CIC’s current portfolio, to invest in new opportunities created at the University of Cambridge and within the Cambridge Cluster and to expand the CIC team to allow the Company to capitalise on its strong inflow of new investment opportunities. The oversubscribed round was supported by new investors including Woodford Investment Management acting as agent on behalf of certain discretionally managed funds, Winton Ventures, the Oman Investment Fund and other institutional investors and existing shareholders including University of Cambridge Endowment Fund, Lansdowne Partners, ARM and IP Group plc. CIC is led by a strong and diverse Board and management team. Edward Benthall is Non-Executive Chairman and was Chairman of Cambridge Enterprise Ltd between 2010 and 2014. Victor Christou, Chief Executive Officer, has 20 years of experience as both a venture capital investor and as an entrepreneur, founding and forming a spin out within an academic environment. Rob Sprawson, CIC’s Chief Financial Officer, has considerable professional and commercial experience especially in the healthcare, technology and IP commercialisation sectors.